Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies
Klaus Podar and Kenneth C. Anderson

Cytokines As Anti-Angiogenic Agents In Haematological Malignancies
Claudia Cocco, Elisa Ferretti, Irma Airoldi and Vito Pistoia

Anti-angiogenic therapies in the treatment of Waldenstrom’s Macroglobulinemia
Antonio Sacco, Irene M. Ghobrial and Aldo M. Roccaro

Antiangiogenic Therapies in Non-Hodgkin’s Lymphoma
Jia Ruan

Epha2-Dependent Molecular Targeting Therapy for Malignant Tumors
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan

Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Jijun Cheng , Jie Xu, Jinzhong Duanmu , Han Zhou , Carmen J. Booth and Zhiwei Hu

The hypomethylation agent bisdemethoxycurcumin acts on the WIF-1 promoter, inhibits the canonical Wnt pathway and induces apoptosis in human non-small-cell lung cancer
Yu-liang Liu, He-ping Yang, Xiang-dong Zhou, Liang Gong, Chun-lan Tang and Hai-jing Wang

Clinical experience with antiangiogenic therapy in leukemia
Jasmin Otten and Walter Fiedler

Antiangiogenic in Myelodysplastic Syndrome
Alvaro Aguayo, Flor M. Armillas-Canseco and Deborah Martínez-Baños

New alkyl-lipid blockers of SK3 channels reduce cancer-cell migration and occurrence of metastasis
Alban Girault, Jean-Pierre Haelters, Marie Potier, Aurelie Chantome, Michelle Pinault, Severinne Marionneau-Lambot, Thibauld Oullier, Gaelle Simon, Helene Couthon-Gourves, Paul-Alain Jaffres, Bernard Corbel, Philippe Bougnoux, Virginie Joulin, Christophe Vandier

Editorial: Novel and emerging drugs for leukemias
Tadeusz Robak

Novel And Emerging Drugs For Acute Myeloid Leukemia
Eytan M. Stein and Martin S. Tallman

Emerging therapies in chronic myeloid leukemia
Joanna Gora-Tybor

Novel and emerging drugs for rarer chronic lymphoid leukaemias
Estella Matutes

Novel and emerging drugs for acute lymphoblastic leukemia
Ewa Lech-Maranda and Wojciech Mlynarski

Novel and emerging drugs for acute lymphoblastic leukemia
Ewa Lech-Maranda and Wojciech Mlynarski

Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development In Mice
Ming-Yue Li, Angel WY Kong, Huiling Yuan, Lily T Ma, Michael K.Y. Hsin, Innes YP Wan, Malcolm J Underwood and George G Chen

Structural Comparison of the Interaction of Tubulin with Various Ligands Affecting Microtubule Dynamics
Emilia Stec-Martyna, Marco Ponassi, Mariangela Miele, Stefania Parodi, Lamberto Felli and Camillo Rosano

Cyclooxygenase-2 (COX-2) Mediates Arsenite Inhibition of UVB-induced Cellular Apoptosis in Mouse Epidermal Cl41 cells
Zhenghong Zuo, Weiming Ouyang, Jingxia Li, Max Costa and Chuanshu Huang

High Cxcr4 Expression Correlates With Sunitinib Poor Response In Metastatic Renal Cancer
D’Alterio Crescenzo, Portella Luigi, Ottaiano Alessandro, Rizzo Mimma, Carteni Giacomo, Pignata Sandro, Facchini Gaetano, Perdonà Sisto, Di Lorenzo Giuseppe, Autorino Riccardo, Franco Renato, La Mura Anna, Nappi Oscar, Castello Giuseppe and Scala Stefania

Growth Suppression and Mitotic Defect Induced by JNJ-7706621, an Inhibitor of Cyclin-Dependent Kinases and Aurora Kinases
Aya Matsuhashi, Takatoshi Ohno, Masashi Kimura, Akira Hara, Masanao Saio, Akihito Nagano, Gou Kawai, Mitsuru Saitou, Iori Takigami, Kazunari Yamada, Yukio Okano and Katsuji Shimizu

Lycopene modulation of molecular targets affected by smoking exposure
Paola Palozza, Rossella Simone, Assunta Catalano, Marco Russo and Volker Böhm

Polysialyltransferase: a new target in metastatic cancer
Robert A. Falconer, Rachel J. Errington, Steven D. Shnyder, Paul J. Smith and Laurence H. Patterson

Inhibition of Protein N-Myristoylation: A Therapeutic Protocol in Developing Anticancer Agents
U. Das, S. Kumar, J. R. Dimmock and R. K. Sharma

Novel and emerging drugs for chronic lymphocytic leukemia
Susanne Isfort, Paula Cramer and Michael Hallek

Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition
Ana Ramírez de Molina, Ana de la Cueva, Rosario Machado-Pinilla, Vanessa Rodríguez-Fanjul, Teresa Gómez del Pulgar, Arancha Cebrián, Rosario Perona and Juan Carlos Lacal

A molecular signature for oncogenic BRAF in human colon cancer cells is revealed by microarray analysis
Tobias Joyce, Eftychia Oikonomou, Vivian Kosmidou, Eleni Makrodouli, Ioannis Bantounas, Spiros Avlonitis, Georgios Zografos and Alexander Pintzas

Emerging roles for modulation of microRNA signatures in cancer chemoprevention
Karthik Neelakandan, Pradeesh Babu and Sujit Nair

The impact of proteomics in the understanding of the molecular basis of paclitaxel-resistance in ovarian tumors
Daniele Vergara, Andrea Tinelli, Anna Iannone and Michele Maffia

Increased Expression of Matrix Metalloproteinases Mediates Thromboxane A₂-Induced Invasion in Lung Cancer Cells
Xiuling Li and Hsin-Hsiung Tai

Anti-tumor effect of AlkB homolog 3 knockdown in hormone-independent prostate cancer cells
Kazuhisa Koike, Yuko Ueda, Hiroaki Hase, Kaori Kitae, Yasuyuki Fusamae, Seiko Masai, Takaaki Inagaki, Yasuka Saigo, Shinji Hirasawa, Kazuhiro Nakajima, Ikumi Ohshio, Yasutake Makino, Noboru Konishi, Hiroshi Yamamoto and Kazutake Tsujikawa